32
Participants
Start Date
March 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
ranibizumab
0.5 ml 10mg/ml (0.5 mg) ranibizumab for intravitreal injection. Monthly injection for 3 months, followed by reinjection if edema for a total of 6 months.
ranibizumab
Sham injection with an empty, sterile 3-ml stopped glass vial. # monthly sham-injections, followed by reinjection for 3 months if present edema.
Bettina Kinge, Retinaklinikken Aleris, Oslo
Ingar Stene Johansen, Oslo
Vegard Forsaa, Stavanger
Kristian Fossen, Tromsø
Collaborators (1)
Novartis
INDUSTRY
Aleris Helse
OTHER